Children with severe epilepsy have significantly fewer seizures when treated with a prescription derivative of marijuana, researchers revealed.

Epidolex – a pharmaceutical liquid form of cannabidiol, an active ingredient in marijuana – is currently undergoing US Food and Drug Administration-authorized phase 3 testing.

Three studies presented at the American Epilepsy Society’s annual meeting showed the drug to be effective on children with treatment-resistant forms of epilepsy. 

Dr Orrin Devinsky of New York University Langone Medical Center, lead author of the study, said: ‘We are pleased to report these promising data on significant numbers of children.

‘These data reinforce and support the safety and efficacy we have shared in previous studies.

In a matter of weeks, the state of New York will officially launch its medical marijuana program. However, the word on the street is although state officials claim the “program remains on track for full implementation” by January 2016, only a slight few will actually have access to this medicine because there aren’t many doctors qualified to offer patient recommendations.

While the nation’s 50 states remain divided on the legalization of marijuana, New York’s Compassionate Care Act has freed marijuana companies to open dispensaries in the nation’s largest city, capturing the attention of accredited investors nationwide.

The law legalizes certain types of medical marijuana in the Empire State and is expected to lead to the opening up of the state’s first marijuana dispensary in New York City in January—a development seen by some as a significant boost to bringing more investment dollars into the cannabis industry.

Curaleaf said it can provide New York with medical marijuana 'tomorrow'

Cannabis treatment is helpful for some diseases. Some countries legally approved use of marijuana.

3 Surprising Industries That Would Benefit if Marijuana Was Legalized

When it comes to fast-growing industries, there may be none with better growth prospects than marijuana. Based on some estimates, legalizing marijuana across the country could lead to a $35 billion market. Separately, NerdWallet has suggested that legalizing marijuana would generate around $3.1 billion in annual tax revenue for states and potentially the federal government.

Growing a plant that’s still illegal to cultivate under most circumstances requires special growing practices. But companies in New York say they expect to meet a Jan. 1 deadline to get medical marijuana on the market.

The state granted five licenses for growing legal marijuana for medicinal purposes in July, and qualifying patients must have a special prescription to get it. Forty-three companies vied for the five available licenses; one of the stipulations was being ready to dispense by Jan. 1.

Chuck Schmitt, director of horticulture for Vireo Health of New York, which manufactures in Fulton County and will dispense in Broome, Albany, Westchester and Queens counties, said the company is on target for the Jan. 1 launch date.

Cops received a tip that a shipment of drugs would be coming in from Seattle, and found 290 pounds of marijuana and mushrooms in a shipping container.

Seattle sent a slew of drugs our way — more than 290 pounds of marijuana and mushrooms.

Cops seized a shipping container on the Brooklyn waterfront loaded with wacky weed and other drugs, law enforcement sources said Saturday.

Cops found the container at a Maspeth Ave. dock in East Williamsburg near the Newtown Creek on Wednesday after Homeland Security tipped them off that a cargo container full of drugs was coming to Brooklyn from Seattle.

On Thursday evening, cops watched as two men and a woman pulled up in a U-Haul truck and a Hyundai.

With more and more states legalizing Marijuana it’s about time the business world catches up and starts preparing for a whole new industry. The company that is taking this on…Leaflink. With the easy to order B2B wholesale platform, they are setting themselves up in a surging market to only grow and grow over time.

Founder Ryan Smith talks with AlleyWatch about how his business among controversy and how they raised capital nonetheless.

Ryan Smith

A new study of participants in opioid treatment programs in New York City reports a notable shift in the demographics of this population in the past 15 years. The study, “Demographic Trends of Adults in New York City Opioid Treatment Programs—An Aging Population,” reports that “In 1996, the majority of adults in opioid treatment were less than 40 years of age, while in 2012, the majority age group in opioid treatment were those 50 to 59 (7.8% to 35.9%), with large increases in those over the age of 60 (1.5% to 12.0%).” In addition, the race and ethnicity of program participants has become increasingly white, in the 60+ population, and increasingly Hispanic among the 50 to 59 cohort.

Cannabis use is associated with improved outcomes in opioid-dependent subjects undergoing outpatient treatment, according to data published online ahead of print in the journal Drug and Alcohol Dependence.